-+ 0.00%
-+ 0.00%
-+ 0.00%

Nanexa Grants Moderna License to Use PharmaShell Drug Delivery Platform with First Compound

MT Newswires·12/11/2025 00:59:08
Listen to the news
12:59 AM EST, 12/11/2025 (MT Newswires) -- Nanexa (NANEXA.ST) said Wednesday it granted pharmaceutical giant Moderna (0QF.F) the license to use its PharmaShell drug delivery platform with the first selected compound. The deal includes options for up to four additional compounds, which, if exercised, will trigger a pre-negotiated license. The Swedish company will receive a $3 million upfront payment and the right to receive up to $500 million in potential milestone payments and a tiered single-digit royalty on future sales under the agreement.